Moxifloxacin Concentrate for Infusion Solution 20 mg/ml, 20 ml Vial

The Municipal Non-Commercial Enterprise "City Clinical Hospital No. 11" of Odesa City Council is issuing a tender for the procurement of Moxifloxacin concentrate for infusion solution. Each vial contains 20 mg/ml of the active substance and has a volume of 20 ml. This medication falls under the broader category of anti-infectives for systemic use, vaccines, antineoplastics, and immunomodulators, with the specific CPV code being 33650000-1. Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic used to treat various bacterial infections. The tender indicates a need for this specific pharmaceutical product for patient treatment within the hospital. The requirement for a concentrate for infusion solution suggests it will be diluted before administration to patients, likely in intensive care or for severe infections. The hospital is seeking a reliable supply of this essential medication to ensure continuity of care for its patients. Detailed specifications on packaging, shelf life, and delivery terms are expected in the full tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 400,180.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.